BenQ Materials, part of the BenQ Qisda Group, announced on May 22 that it completed a five-year syndicated loan of NT$6 billion (US$190.4 million) led by E.SUN Bank to refinance debt and support its transition to a cross-industry materials platform. The facility drew participation from 10 financial institutions, was oversubscribed by 1.9 times, and includes sustainability-linked interest-rate discounts tied to ESG targets.
According to the company, the loan proceeds will primarily repay existing bank borrowings and bolster mid-term working capital as it accelerates strategic initiatives. Executives framed the financing as a vote of confidence from lenders in the firm's long-term management and transformation capabilities, with the sustainability linkage reflecting the company's push for greener operations.
BenQ Materials said it has organized its platform around three core directions. Firstly, it is accelerating its medical business by applying materials science to a medical technology platform spanning different stages of care. The company reported expansion into five areas: professional clinical use, sterilization packaging, advanced medical materials, vision care and skin care, and projected that medical revenue will approach nearly 40% of total sales in 2026.
Secondly, the firm intends to deepen its presence in advanced semiconductor manufacturing by entering the high-end critical consumables segment. The company listed targeted products, including high-end polyvinyl alcohol air-foamed chemical-mechanical polishing cleaning brushes, BG tape, optical fiber component adhesives, micro-contamination control films, and dry film photoresist, and said it will accelerate market deployment for semiconductor-critical consumables.
Thirdly, BenQ Materials said it will strengthen core technologies and enhance high-resolution display materials. Originating in polarizer production, the company reported continued investments to deepen high-end capabilities in core display materials while providing stable resources and technical support for cross-industry integration of emerging materials, positioning the firm to serve the medical, semiconductor, and display markets concurrently.
Article edited by Jingyue Hsiao
